HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefin a and stefin B: markers for prognosis in operable squamous cell carcinoma of the head and neck.

AbstractPURPOSE:
The aim of this study was to test the hypothesis about the protective role of high stefin A and stefin B concentrations in operable carcinoma of the head and neck.
METHODS AND MATERIALS:
Stefins A and B concentrations were measured in tissue cytosols of nontumorous mucosa and primary tumors from 92 patients. For quantitative analysis of stefins in tumor cytosols, commercially available enzyme-linked immunosorbent assays were used.
RESULTS:
Stefin A was upregulated in 53 patients (higher concentrations were measured in tumor samples than in nontumorous mucosa) and was downregulated in 39 patients. The corresponding numbers for stefin B were 49 and 43, respectively. A significantly higher proportion of downregulated cases were found among patients with disease re-appearance. In the Cox model, high stefin A concentrations appeared as independent predictors for favorable disease-free survival. Assuming a "broken stick" model, a significant increase in the recurrence rate after the threshold of 1063 ng/mgp (the 64th percentile in the group) was found, the hazard ratio reaching 3% of the reference value with doubling of the level of stefin A. These results were reconfirmed after pooling the data with two historical data sets into a uniform series involving 182 patients.
CONCLUSIONS:
A group of patients at high risk for disease progression was identified, characterized by the downregulated stefin A protein in the tumor compared with the nontumorous mucosa. Stefin A was recognized as a promising candidate marker for prognosis in patients with operable carcinoma of the head and neck.
AuthorsPrimoz Strojan, Aleksandar Anicin, Branka Svetic, Maja Pohar, Lojze Smid, Janko Kos
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 68 Issue 5 Pg. 1335-41 (Aug 01 2007) ISSN: 0360-3016 [Print] United States
PMID17418975 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CSTB protein, human
  • Cystatin A
  • Cystatins
  • Neoplasm Proteins
  • CSTA protein, human
  • Cystatin B
Topics
  • Adult
  • Aged
  • Carcinoma, Squamous Cell (blood, radiotherapy, surgery)
  • Cystatin A
  • Cystatin B
  • Cystatins (blood)
  • Female
  • Head and Neck Neoplasms (blood, radiotherapy, surgery)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins (blood)
  • Prognosis
  • Prospective Studies
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: